Search
IHPA Annual Report 2019–20
Resource
The Independent Hospital Pricing Authority (IHPA) Annual Report for financial year 2019–20.
Emergency department care FAQs – Part 2 (Published 17 September 2020)
Resource
FAQs to support the classification of COVID-19 in emergency department care.
Pricing Framework for Australian Public Hospital Services 2021–22 open for public consultation
News
The Independent Hospital Pricing Authority (IHPA) today released its Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2021–22.
Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2021–22
Resource
The Independent Hospital Pricing Authority (IHPA) released its Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2021–22. Public consultation was open from Wednesday 9 September to 5pm AEDT Friday 9 October 2020. IHPA’s Pricing Framework for Australian Public Hospital Services is revised and published each year. It outlines the principles, scope and methodology adopted by IHPA to determine the National Efficient Price (NEP) and the National Efficient Cost (NEC) Determinations for Australian public hospital services for the specific financial year. All submissions will be published on IHPA's website unless respondents specifically identify any sections they believe should be kept confidential due to commercial or other reasons.
Assessment of new health technologies 2020–21
Resource
The Independent Hospital Pricing Authority’s (IHPA) core function is the pricing of public hospital services. IHPA’s Pricing Guidelines recognise that the 'Pricing of public hospital services should respond in a timely way to introduction of evidence-based, effective new technology and innovations in the models of care that improve patient outcomes.'
Consultation and review of the AR-DRG and ICD-10-AM/ACHI/ACS Classification Systems
Resource
The development cycle of the admitted care classifications was last reviewed in 2009. Since that time the landscape has changed significantly with the National Health Reform Agreement in 2011 and the introduction of activity based funding nationally. The recent review found the cycle was working well but found areas of potential refinement.
COVID-19 Response - Costing and Pricing Guidelines
Resource
This document guides costing practitioners on the steps to capturing end-to-end COVID-19 activity and expenses under the National Partnership Agreement (NPA). It identifies the principles to be applied, the scope of activity and costs to be funded, cost allocation methods and NPA specific cost centres for cost allocation. This document also introduces two new non-patient products and provides information on how to create and map intermediate products.
IHPA Work Program 2020–21
Resource
The Independent Hospital Pricing Authority Work Program has been prepared in accordance with the requirements of section 225 of the National Health Reform Act 2011.
Chimeric antigen receptor T cell therapy (CAR-T cell) - guidelines for costing, counting and reconciliation of funding
Resource
The guidelines set out the scope, funding, costing, counting and reconciliation of funding for the chimeric antigen receptor T cell therapy (CAR-T cell) immunotherapy program using the Novartis CAR-T product Kymriah. The CAR-T program is for paediatric and young adults (up to 25 years) with Acute Lymphoblastic Leukaemia (ALL) who relapse or do not respond to initial therapy.
Impact of New Health Technology Framework Version 4.4
Resource
IHPA recognises the need for the pricing of public hospital services to respond in a timely manner to the introduction of new health technologies and innovations in models of care.
Emergency department care FAQs – Part 1 (Published 25 May 2020)
Resource
FAQs to support the classification of COVID-19 in emergency department care.
Mental Health Phase of Care Clinical Refinement Project Final Report
Resource
Following the completion of the 2016 Inter-Rater Reliability (IRR) study to test the consistency of clinician application of the mental health phase of care, the poor to fair reliability outcome led to the commencement of the refinement project. The project aims to identify the reason for the poor IRR and to improve reliability. This report outlines the clinical findings and recommendations to refine the mental health phase of care. This report was approved by the Pricing Authority in November 2019.